FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

21536711000001106: Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Dec 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71608901000001117 Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
71609001000001110 Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Is a Darunavir 100mg/ml oral suspension sugar free true Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Has active ingredient Darunavir true Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Has specific active ingredient Darunavir ethanolate true Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Darunavir true Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Is a Prezista true Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Has manufactured dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Has basis of strength substance Darunavir true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) 200 ml Has AMP True Prezista 100mg/ml oral suspension (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start